Abbott Laboratories buy Royal Bank of Canada
Start price
19.04.24
/
50%
€98.67
Target price
19.04.25
€117.41
Performance (%)
-1.85%
Price
14.06.24
€96.84
Summary
This prediction is currently active. With a performance of -1.85%, the BUY prediction for Abbott Laboratories by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 19.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | -2.781% | -2.781% |
iShares Core DAX® | -2.926% | -4.228% |
iShares Nasdaq 100 | 4.462% | 8.605% |
iShares Nikkei 225® | 0.306% | 0.284% |
iShares S&P 500 | 2.488% | 4.773% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Royal Bank of Canada from $128.00 to $125.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€94.80
04.06.24
04.06.24
€114.98
04.06.25
04.06.25
2.15%
14.06.24
14.06.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.16
14.02.24
14.02.24
€119.35
14.02.25
14.02.25
-6.53%
14.06.24
14.06.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.54
25.01.24
25.01.24
€118.09
25.01.25
25.01.25
-5.06%
14.06.24
14.06.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.98
11.01.24
11.01.24
€116.90
11.01.25
11.01.25
-4.97%
14.06.24
14.06.24